Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-11

Clinical Trial Update: Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

View source ↗

Summary

Clinical trial comparing ATLG versus ATG for immune reconstitution after allogeneic hematopoietic stem cell transplantation in hematologic malignancies; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATG (anti-thymocyte globulin)
  • ATLG (anti-T lymphocyte globulin)

Snippet

Sponsor: Peking University First Hospital | Conditions: Leukemia, MDS | Status: RECRUITING